Antigenics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
http://www.companiesandmarkets.com/Summary-Company-Profile/antigenics,-inc.-pharmaceuticals-healthcare-deals-and-alliances-profile-164462.asp
- Market - Healthcare and Medical
- Published Date - 01/07/2009
- Report Type - Company Profile
- Country - Global
- Number of Pages - 17
- Electronic - £161.00
- Site Licence - £321.00
- Corporate Licence - £481.00
Report Summary
Antigenics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Antigenics Inc. (Antigenics) is a biotechnology company. The company is focused on the developing superior health care products and technologies for a wide range of cancers, infectious diseases and autoimmune disorders based on immunological approaches. Its business activities include research and development, regulatory and clinical affairs, manufacturing, business development, marketing, and administrative functions. The company is headquartered in New York, United States.
The Antigenics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick "one-stop-shop" to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
Table of Contents
Table Of Contents
Table Of Contents 2
List of Tables 2
List of Figures 2
Antigenics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 3
Antigenics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 4
Antigenics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 5
Antigenics, Inc., Pharmaceuticals & Healthcare, Deals By Sector, 2004 to YTD 2009 6
Antigenics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 7
Antigenics, Inc., Pharmaceuticals & Healthcare, Deal Details 8
Antigenics Completes Private Placement Of 8% Senior Notes For $25 Million 8
Antigenics Completes Private Placement Of 5.25% Senior Notes For $50 Million 9
Equity Offering 10
Antigenics Completes Private Placement Of $0.8 Million 10
Antigenics Completes Private Placement Of $21 Million 11
Antigenics Completes Private Placement Of $26 Million 12
Antigenics Completes Private Placement Of $5 Million 13
Antigenics Completes Public Offering Of $56.7 Million 14
Partnerships 15
GlaxoSmithKline Extends Licensing Agreement With Antigenics 15
Key Competitors 16
Key Employees 16
Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About Global Markets Direct 17
Contact Us 17
Disclaimer 17
List of Tables
Antigenics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 3
Antigenics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 4
Antigenics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 5
Antigenics, Inc., Deals By Sector, 2004 to YTD 2009 6
Antigenics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 7
Antigenics Completes Private Placement Of 8% Senior Notes For $25 Million 8
Antigenics Completes Private Placement Of 5.25% Senior Notes For $50 Million 9
Antigenics Completes Private Placement Of $0.8 Million 10
Antigenics Completes Private Placement Of $21 Million 11
Antigenics Completes Private Placement Of $26 Million 12
Antigenics Completes Private Placement Of $5 Million 13
Antigenics Completes Public Offering Of $56.7 Million 14
GlaxoSmithKline Extends Licensing Agreement With Antigenics 15
Antigenics, Inc., Key Employees 16
List of Figures
Antigenics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 3
Antigenics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2004 to YTD 2009 4
Antigenics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 5
Antigenics, Inc., Pharmaceuticals & Healthcare, Deals by Sector, 2004 to YTD 2009 6